Seed7 October 2026

Cori Clinical raises $4m in seed funding to expand its clinical intelligence platform

The round was led by Breega to support delivery capacity and team growth.

$4.0MSeed

≈ £3.0M at $1 = £0.7574 on 7 Oct 2026

Cori Clinical builds an artificial intelligence workspace designed to help pharmaceutical sponsors and contract research organisations test trial designs against historical studies and regulator guidance.

London-based Cori Clinical has secured $4m in a seed funding round led by Breega. Additional participants in the financing included Enzo Ventures, Heartfelt, Together Ventures, and Bynd.

The startup plans to deploy the capital to increase its delivery capacity, recruit engineering, clinical, and commercial personnel, and enhance the regulatory and clinical intelligence embedded in its platform.

Cori Clinical develops an artificial intelligence workspace that aggregates internal trial records with external regulatory guidance to help teams draft protocols and operational plans before trials commence.

Investor perspective

"Clinical trials are built through a series of interconnected decisions about how a study should be designed and run. Today, much of the knowledge and precedent behind those decisions is scattered across previous trials, siloed teams, internal systems and separate documents. Cori brings that intelligence together into a living blueprint, so teams can make better-informed decisions before avoidable problems become delays, so the science never waits on the process,"